Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Somatostatin | Somatostatin is an endogenous peptide that inhibits the release of growth hormone, insulin and glucagon. Somatostatin also blocks voltage-dependent calcium channels. Uses: Hormones. Synonyms: Somatostatin 14; Somatostatin-14; Panhibin; Somiaton. Grades: 98%. CAS No. 51110-01-1. Molecular formula: C76H104N18O19S2. Mole weight: 1637.88. |  |
| Somatostatin-14 (3-14) | Somatostatin-14 (3-14) is an exquisite peptide analog harnessed extensively for biomedical research, epitomizes a remarkable resemblance to the native hormone somatostatin. Exerting its influence as an agonist dedicated to specific somatostatin receptors, this product exudes exquisite potential in unveiling the intricacies of ailments such as acromegaly, carcinoid syndrome and pancreatic neuroendocrine tumors, all intertwined with the enigmatic somatostatin receptors. Synonyms: H-D-Cys-D-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-D-Phe-Thr-Ser-Cys-OH (Disulfide bridge: Cys1-Cys12); D-cysteinyl-D-lysyl-L-asparagyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-D-phenylalanyl-L-threonyl-L-seryl-L-cysteine (1->12)-disulfide; 1,2-Dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontane-4-carboxylic acid, 37-amino-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-13,25,28-tris(phenylmethyl)-, (4R, 7S, 10S, 13R, 16S, 19S, 22R, 25S, 28S, 31S, 34R, 37S)-. Grades: ≥95%. CAS No. 54518-51-3. Molecular formula: C71H96N16O17S2. Mole weight: 1509.77. | |
| Somatostatin-25 | Somatostatin-25 is a endogenous neuropeptide hormone that shows inhibitory activity against secretion of growth hormone. Synonyms: SER-ASN-PRO-ALA-MET-ALA-PRO-ARG-GLU-ARG-LYS-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS; H-SER-ASN-PRO-ALA-MET-ALA-PRO-ARG-GLU-ARG-LYS-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS-OH. CAS No. 76461-17-1. Molecular formula: C127H191N37O34S3. Mole weight: 2876.29. | |
| Somatostatin-28 | Somatostatin-28 is an exceptionally significant neuropeptide hormone extensively employed in the compound field, acting as a superbly adept endogenous modulator of neurotransmitters and hormones. Synonyms: Prosomatostatin; 73032-94-7; Somatostatin 28; Somatostatin-28 (sheep) 28; UNII-14EBZ2F8O6; 14EBZ2F8O6; SRIF-28; SOMATOSTATIN 28, CYCLIC; Somatostatin 28, >=97% (HPLC); LS-15547; LS-145641; FT-0689038. Grades: ≥95%. CAS No. 75037-27-3. Molecular formula: C137H207N41O39S3. Mole weight: 3148.6. | |
| Somatostatin-28 (1-14) | Somatostatin-28 (1-14) has been used to produce antibodies selective for somatostatin-28 that do not bind to the C-terminal fragment somatostatin-14. Synonyms: H-SER-ALA-ASN-SER-ASN-PRO-ALA-MET-ALA-PRO-ARG-GLU-ARG-LYS-OH. CAS No. 79243-10-0. Molecular formula: C61H105N23O21S. Mole weight: 1528.71. | |
| Somatostatin-28 (sheep) | Somatostatin-28 (sheep) is derived from posttranslational cleavage of prosomatostatin, which in turn is derived from a larger precursor, preprosomatostatin. S-28 is an octacosapeptide first isolated from the duodenum of pigs. Unlike S-14, S-28 increases amylase secretion, cellular cyclic GMP and Ca2+ outfluxes in the guinea pig pancreatic acini. Synonyms: H-Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bridge: Cys17-Cys28); Somatostatin 1-28; L-seryl-L-alanyl-L-asparagyl-L-seryl-L-asparagyl-L-prolyl-L-alanyl-L-methionyl-L-alanyl-L-prolyl-L-arginyl-L-alpha-glutamyl-L-arginyl-L-lysyl-L-alanyl-glycyl-L-cysteinyl-L-lysyl-L-asparagyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine (17->28)-disulfide; 1,2-Dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontane, cyclic peptide deriv.; Cyclic somatostatin-28; Human somatostatin-28; Somatostatin-28 (human); Somatostatin-28 (pig); Somatostatin-28 (rat); Somatostatin-28 (sheep reduced), cyclic (17?28)-disulfide. Grades: ≥95% by HPLC. CAS No. 73032-94-7. Molecular formula: C137H207N41O39S3. Mole weight: 3148.56. | |
| Somatostatin Acetate | Growth hormone-release inhibiting factor; treatment of severe, acute hemorrhage of gastroduodenal ulcers; experimental antidiabetic. Group: Biochemicals. Alternative Names: Aminopan. Grades: Highly Purified. CAS No. 38916-34-6. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| Somatostatin Impurity 1 | Somatostatin Impurity 1. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C76H102N18O18S2. Mole Weight: 1619.88. Catalog: APB12217. |  |
| Somatostatin monoacetate | Somatostatin monoacetate is a peptide hormone. It regulates the endocrine system and affects neurotransmission and cell proliferation by interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones. It inhibits insulin and glucagon secretion. Synonyms: Somatostatin (sheep), monoacetate (salt); H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH.CH3CO2H (Disulfide bridge: Cys3-Cys14); L-alanyl-glycyl-L-cysteinyl-L-lysyl-L-asparagyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine (3->14)-disulfide acetic acid. Grades: 98%. CAS No. 54472-66-1. Molecular formula: C78H108N18O21S2. Mole weight: 1697.95. | |
| Somatostatin (Sheep) | It is a growth hormone-release inhibiting factor used in the treatment of severe, acute hemorrhages of gastroduodenal ulcers. It's an experimental diabetes drug. Uses: Growth hormone-release inhibiting factor; treatment of severe, acute hemorrhage of gastroduodenal ulcers; experimental antidiabetic. Synonyms: SRIF-14; Somatostatin-14; H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bridge: Cys3-Cys14); Cyclic somatostatin; 15-28-Somatostatin-28 (sheep); 15:PN:WO2007081792 SEQID:30 claimed protein. Grades: >98%. CAS No. 38916-34-6. Molecular formula: C76H104N18O19S2. Mole weight: 1637.88. | |
| (3-cyanoalanine) somatostatin | (3-cyanoalanine) somatostatin. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C76H102N18O18S2. Mole Weight: 1619.88. Catalog: APB10183. | |
| Cyclic somatostatin diacetate | Cyclic somatostatin diacetate is a growth hormone-release inhibiting factor used in the treatment of severe, acute hemorrhages of gastroduodenal ulcers. It's an experimental diabetes drug. Synonyms: Somatostatin (sheep), diacetate (salt); H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH.2CH3CO2H (Disulfide bridge: Cys3-Cys14); L-alanyl-glycyl-L-cysteinyl-L-lysyl-L-asparagyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine (3->14)-disulfide diacetic acid; Somatostatin diacetate. Grades: ≥95%. CAS No. 73977-20-5. Molecular formula: C76H104N18O19S2.2C2H4O2. Mole weight: 1757.99. | |
| Cyclosomatostatin | Cyclosomatostatin is a non-selective somatostatin (sst) receptor antagonist. It blocks the effects of CRF-induced suppression of gastric empyting and sst on airway β-adrenergic function. It also prevents growth hormone, insulin, glucagon release and modulation of ACh release. It acts as a sst receptor agonist in human neuroblastoma cell line SH-SY5Y. Uses: Hormone antagonists. Synonyms: Cyclo(7-aminoheptanonyl-Phe-D-Trp-Lys-Thr[Bzl]); Cyclo[7-aminoheptanoyl-L-phenylalanyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-threonyl]. CAS No. 84211-54-1. Molecular formula: C44H57N7O6. Mole weight: 779.98. | |
| Cyclosomatostatin acetate | Cyclosomatostatin acetate is an effective antagonist of the somatostatin receptor. Cyclosomatostatin acetate inhibits SSTR1 signaling and decreases cell proliferation, ALDH+ cell population size, and sphere-formation in colorectal cancer cells. Synonyms: 1,4,7,10,13-Pentaazacycloeicosane-2,5,8,11,14-pentone, 6-(4-aminobutyl)-9-(1H-indol-3-ylmethyl)-3-[(1R)-1-(phenylmethoxy)ethyl]-12-(phenylmethyl)-, acetate (1:1), (3S,6S,9R,12S)-; Cyclo[7-aminoheptanoyl-L-phenylalanyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-threonyl], monoacetate; Cyclo-Somatostatin acetate. Grades: ≥95%. CAS No. 211056-95-0. Molecular formula: C44H57N7O6.C2H4O2. Mole weight: 840.02. | |
| (d-2-Nal5,cys6'11,tyr7,d-trp8,val10,2-nal12)-somatostatin-14(5-12)amide | Heterocyclic Organic Compound. Alternative Names: H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-2-NAL-NH2;(D-2-NAL5,CYS6'11,TYR7,D-TRP8,VAL10,2-NAL12)-SOMATOSTATIN-14 (5-12) AMIDE. CAS No. 111857-96-6. Molecular formula: C63H73N11O9S2. Mole weight: 1180.44. Catalog: ACM111857966. |  |
| (D-2-Nal5,Cys6 11,Tyr7,D-Trp8,Val10,2-Nal12)-Somatostatin-14 (5-12) amide | BIM 23042 is a selective neuromedin B receptor (NMB-R, BB1) antagonist (Ki = 216 and 18, 264 nM for BB1 and BB2 receptors, respectively) displaying no effect on a range of other receptors. Synonyms: H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-2-NAL-NH2; BIM 23042. CAS No. 111857-96-6. Molecular formula: C62H73N11O9S2. Mole weight: 1180.44. | |
| des-Thrl0-somatostatin | des-Thrl0-somatostatin. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C72H97N17O17S2. Mole Weight: 1536.79. Catalog: APB10184. | |
| Dihydrosomatostatin | Synonyms: Somatostatin-14 (reduced); Somatostatin (15-28); H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH. CAS No. 40958-31-4. Molecular formula: C76H106N18O19S2. Mole weight: 1639.89. | |
| (D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide | (D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide, a synthetic somatostatin analogue, is selective for human somatostatin receptor subtype 5 (hsst5) and has similar binding affinity to somatostatin-28, with Kd±SEM values of 1200, 23.5±3.92, 11.05±1.03, >1000 and 0.61±0.36 nM for hsst1, hsst2, hsst3, hsst4 and hsst5, respectively. Synonyms: (N-Me-D-Trp4,Thr8)-Octreotide amide; H-D-Phe-Cys-Phe-N-Me-D-Trp-Lys-Thr-Cys-Thr-NH2 (Disulfide bridge: Cys2-Cys7); D-phenylalanyl-L-cysteinyl-L-phenylalanyl-N-methyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninamide (2->7)-disulfide. Grades: ≥95% by HPLC. CAS No. 340821-13-8. Molecular formula: C50H67N11O10S2. Mole weight: 1046.26. | |
| (D-Phe7)-Somatostatin-14 | Synonyms: H-Ala-Gly-Cys-Lys-Asn-Phe-D-Phe-Trp-Lys-Thr-Phe-Thr-Ser-D-Cys-OH. CAS No. 64813-74-7. Molecular formula: C76H104N18O19S2. Mole weight: 1637.88. | |
| Prosomatostatin | Somatostatin 1-28 is a somatostatin receptor agonist derived from the post-translational cleavage of prosomatostatin. Synonyms: Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge: Cys17-Cys28); Somatostatin, pro-; ProSRIF; Somatostatin 1-28; SRIF-28; SRIF 28; SRIF28; Somatostatin 28. Grades: >98%. CAS No. 74315-46-1. Molecular formula: C137H207N41O39S3. Mole weight: 3148.55. | |
| [Tyr1]-Somatostatin | Synonyms: Tyr(1)-somatostain 14; 1-N-Tyr-somatostatin; Tyr-8-trp-somatostatin 14; Somatostatin, N-tyr(1)-. CAS No. 59481-23-1. Molecular formula: C82H108N18O20S2. Mole weight: 1729.97. | |
| Tyr-(D-Dab4,Arg5,D-Trp8)-cyclo-Somatostatin-14 (4-11) | Tyr-(D-Dab4,Arg5,D-Trp8)-cyclo-Somatostatin-14 (4-11), a high affinity ligand of five somatostatin receptors (SST1-SST5), has higher binding affinity than omatostatin-14 and octreotide in AtT-20 mouse anterior pituitary tumor cells expressing SST2 and SST5 receptors. Synonyms: KE 108; H-Tyr-cyclo(-D-Dab-Arg-Phe-Phe-D-Trp-Lys-Thr-Phe); L-Tyrosyl-(2R)-2,4-diaminobutanoyl-L-arginyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanine (9?2)-lactam; Benzenepropanamide, α-amino-N-[(3S,6S,9S,12R,15S,18S,21S,24R)-9-(4-aminobutyl)-21-[3-[(aminoiminomethyl)amino]propyl]-6-[(1R)-1-hydroxyethyl]-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,23-octaoxo-3,15,18-tris(phenylmethyl)-1,4,7,10,13,16,19,22-octaazacyclohexacos-24-yl]-4-hydroxy-, (αS)-. Grades: 95%. CAS No. 496849-46-8. Molecular formula: C67H85N15O11. Mole weight: 1276.49. | |
| Tyr-Somatostatin-14 | Tyr-Somatostatin-14 is a customized peptide that adds a Tyrosine amino acid to Somatostatin-14. Synonyms: TYR-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS. CAS No. 58100-03-1. Molecular formula: C85H113N19O21S2. Mole weight: 1801.05. | |
| Tyr-Somatostatin-14 acetate | Tyr-Somatostatin-14 acetate is a customized peptide that adds a Tyrosine amino acid to Somatostatin-14. Synonyms: H-Tyr-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH.CH3CO2H (Disulfide bridge: Cys4-Cys15); L-tyrosyl-L-alanyl-glycyl-L-cysteinyl-L-lysyl-L-asparagyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine (4->15)-disulfide acetic acid. Grades: ≥95%. Molecular formula: C87H117N19O23S2. Mole weight: 1861.12. | |
| 13C6-Lys Octreotide Trifluoroacetate | 13C6-Lys Octreotide Trifluoroacetate, is labelled Octreotide (O239950, acetate salt) which is an analog of Somatostatin (S676750, acetate salt). Octreotide (O239950, acetate salt) is a gastric antisecretory agent and it is used in treatment of acromegaly. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500ug, 5mg. Molecular Formula: C4313C6H66N10O10S2; xC2HF3O2. US Biological Life Sciences. | Worldwide |
| (1R, 1'S, 3'R/1R, 1'R, 3'S)-L-054, 264 | Potent and selective somatostatin sst2 receptor agonist (Ki values are 4, 537, 2480, 3614 and 5017 nM for cloned human sst2, sst1, sst4, sst3 and sst5 receptors respectively). Group: Biochemicals. Grades: Highly Purified. CAS No. 208706-12-1. Pack Sizes: 1mg, 10mg. Molecular Formula: C33H41N5O2. US Biological Life Sciences. | Worldwide |
| (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 | (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 is a selective and potent somatostatin sst2 receptor agonist with Ki value of 4nm. Its Ki values are 537, 3614, 2480 and 5017 nM for cloned human sst1, sst3, sst4 and sst5 receptors respectively. Synonyms: N-[ (1R) -2-[[[ (1S*, 3R*) -3- (Aminomethyl) cyclohexyl]methyl]amino]-1- (1H-indol-3-ylmethyl) -2-oxoethyl]spiro[1H-indene-1, 4'-piperidine]-1'-carboxamide. Grades: ≥96% by HPLC. CAS No. 208706-12-1. Molecular formula: C33H41N5O2. Mole weight: 539.71. | |
| 2-Aminophenol-4-sulfonamide | 3-Amino-4-hydroxy Benzene sulfonamide is a reagent used to synthesize antagonists for somatostatin receptor subtype 5 (SST5R). It also has utility in dye applications. Group: Biochemicals. Grades: Highly Purified. CAS No. 98-32-8. Pack Sizes: 5g, 10g. Molecular Formula: C6H8N2O3S, Molecular Weight: 188.2. US Biological Life Sciences. | Worldwide |
| 3-(Boc-aminomethyl)benzoic Acid | 3-(Boc-aminomethyl)benzoic Acid is used to synthesize aminodi hydroquinazolines as inhibitors of BACE-1 ( β-site APP cleaving enzyme). It is also used to prepare spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists. Group: Biochemicals. Grades: Highly Purified. CAS No. 117445-22-4. Pack Sizes: 500mg, 1g. Molecular Formula: C13H17NO4, Molecular Weight: 251.28. US Biological Life Sciences. | Worldwide |
| 9-Fluorenylmethanol | 9-Fluorenemethanol is used in the design and in the synthesis of novel type somatostatin analogs with antiproliferative activities on A431 tumor cells. Synonyms: Fmoc-OH; Fluorene-9-methanol; (9H-Fluoren-9-yl)methanol; 9-(Hydroxymethyl)fluorene; 9-Fluorenylmethanol; 9-Fluorenylmethyl Alcohol; 9H-Fluorene-9-methanol; 9-Hydroxymethylfluorene; fluoren-9-ylmethan-1-ol; (9h-fluoren-9-yl)methanol; hofm. Grades: ≥ 99 % (HPLC). CAS No. 24324-17-2. Molecular formula: C14H12O. Mole weight: 196.24. | |
| Ac-Octreotide | Ac-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: Ac-D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); N-Acetyl-Phe-Octreotide; L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide; L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide, [R-(R*,R*)]-; N-Acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2?7)-disulfide; D-Phe(Ac)-Octreotide; Ac-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol (Disulfide bridge: Cys2-Cys7). Grades: ≥95%. CAS No. 83795-61-3. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. | |
| BIM 23056 | BIM 23056 is a somatostatin receptor ligand (Ki = 142, > 1000, 10.8, 16.6 and 5.7 nM for human cloned sst1 - 5 receptors respectively). It acts as an antagonist on SRIF14-induced [35S]-GTPγS binding at sst3 and sst5 receptors (PKB = 6.33 and 5.84, respectively). Synonyms: IM 23056; IM23056; IM-23056. Grades: >98%. CAS No. 150155-61-6. Molecular formula: C71H81N11O9. Mole weight: 1232.49. | |
| BIM 23056 acetate | BIM 23056 acetate is a potent and surmountable human recombinant somatostatin receptor antagonist (Ki = 142, >1000, 10.8, 16.6 and 5.7 nM for human cloned sst1-5 receptors, respectively). It acts as an antagonist on SRIF14-induced [35S]-GTPγS binding at sst3 and sst5 receptors (PKB = 6.33 and 5.84, respectively). Synonyms: H-D-Phe-Phe-Tyr-D-Trp-Lys-Val-Phe-D-2Nal-NH2.CH3CO2H; D-phenylalanyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-phenylalanyl-3-(2-naphthyl)-D-alaninamide acetic acid. Grades: ≥95%. CAS No. 2763584-06-9. Molecular formula: C73H85N11O11. Mole weight: 1292.52. | |
| BIM-23627 | BIM 23627 is a somatostatin antagonist with IC50s of 2757, 6.4, 44, 423 and 86.5 nM for five human somatostatin receptor subtypes HSST1, HSST2, HSST3, HSST4 and HSST5, respectively. It selectively binds to human somatostatin receptor subtype 2 (HSST2) with high affinity, but is completely inactive in stimulating intracellular calcium mobilization. Synonyms: H-p-Chloro-Phe-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2 (Disulfide bridge: Cys2 and Cys7). Grades: ≥90%. CAS No. 429619-37-4. Molecular formula: C58H69ClN12O8S2. Mole weight: 1161.85. | |
| Boc-3-(2-naphthyl)-D-alanine | Boc-3-(2-Naphthyl)-D-alanine is a reagent in Lanreotide trisulfide synthesis and somatostatin receptor binding activity. Reagent in the preparation by coupling and structure-activity relationships of arginine containing tripeptides as MC4 receptor ligands. Synonyms: Boc-D-Ala(2-naphthyl)-OH; (αR)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-naphthalenepropanoic Acid; (R)-2-[(tert-Butoxycarbonyl)amino]-3-(naphthalen-2-yl)propionic Acid; BOC-(2-naphthyl)-D-alanine; N-(tert-Butoxycarbonyl)-3-(2-naphthyl)-D-alanine; Boc-3-(2-naphthyl)-D-alanine; BOC-D-2-NAPHTHYLALANINE; N-Boc-3-(2-naphthyl)-L-alanine; N-TERT-BUTOXYCARBONYL-2-NAPHTHYL-D-ALANINE; Boc-2-Nal-OH; N-Boc-3-(2-naphthyl)-D-alanine. Grades: ≥ 99% (HPLC). CAS No. 76985-10-9. Molecular formula: C18H21NO4. Mole weight: 315.36. | |
| Boc-(3-aminomethyl) benzoic acid | Boc-(3-aminomethyl) benzoic acid (CAS# 117445-22-4) is used to synthesize aminodihydroquinazolines as inhibitors of BACE-1 (β-site APP cleaving enzyme). It is also used to prepare spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists. Synonyms: Boc-3-Amb-OH. Grades: ≥ 98 % (HPLC). CAS No. 117445-22-4. Molecular formula: C13H17NO4. Mole weight: 251.27. | |
| Boc-4-(2-chloro-Z-amino)-L-phenylalanine | Used in the synthesis of cyclic somatostatin analogs which bind selectively to somatostatin receptor type 3 (SSTR3). Synonyms: Boc-L-Phe(4-NH-2-CL-Z)-OH; 4-[[[(2-Chlorophenyl)methoxy]carbonyl]amino]-N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanine. Grades: 95%. CAS No. 198475-65-9. Molecular formula: C22H25N2O6Cl. Mole weight: 448.9. | |
| CGP 23996 | CGP 23996 is a non-reducible somatostatin analog. It can be used for autoradiography. Uses: Autoradiography. Synonyms: CGP 23996; CGP23996; CGP-23996. BDBM82467; 2-Deamino-L-Abu(1)-L-Lys-L-Asp(NH2)-L-Phe-L-Phe-L-Trp-L-Lys-L-Thr-L-Tyr-L-Thr-L-Ser-L-Abu(1)-OH;(14R,20S,23R,26R,29R,32R)-2,17-bis(4-aminobutyl)-5-(2-amino-2-oxoethyl)-8,11-dibenzyl-20,26-bis[(1S)-1-hydroxyethyl]-29-(hydroxymethyl)-23-[(4-hydroxyphenyl)methyl]-14-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,38-undecaoxo-1,4,7,10,13,16,19,22,25,28,31-undecazacyclooctatriacontane-32-carboxylic acid. Grades: 98%. CAS No. 86170-12-9. Molecular formula: C73H99N15O18. Mole weight: 1474.66. | |
| CH 275 | CH 275 is a potent somatostatin receptor 1 (sst1) agonist (IC50 = 30.9 nM, 345 nM, > 1 μM, > 10 μM and > 10μM for human sst1, sst3, sst4, sst2 and sst5 respectively). It attenuates somatostatin release in the rat nucleus accumbens. Synonyms: CH 275; CH275; CH-275. CAS No. 174688-78-9. Molecular formula: C74H96N14O15S2. Mole weight: 1485.8. | |
| Cortistatin-14 | Cortistatin-14 is a neuropeptide that shares structural similarities with somatostatin, working by binding to somatostatin receptors ( sst1 - sst5 ). Cortistatin-14 (TFA) has anticonvulsant, neuroprotective effects, and significant anti-inflammatory properties [1] [2] [3]. Uses: Scientific research. Group: Peptides. CAS No. 186901-48-4. Pack Sizes: 500 μg; 1 mg; 5 mg; 10 mg. Product ID: HY-P1932. |  |
| Cortistatin 14, human, rat | Cortistatin 14 is an endogenous neuropeptide similar to somatostatin-14 in structure and function. It is mainly expressed in the cortex and hippocampus. It shows potency at all somatostatin receptors, but prevents somatostatin-14 binding. It binds to the growth hormone secretagog receptor (GHS-R1a). It displays sleep-modulating and neuronal depressant properties in vivo. Synonyms: CST-14, human, rat; Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys (Disulfide bridge: Cys2-Cys13); Corticostatin-14; L-prolyl-L-cysteinyl-L-lysyl-L-asparagyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-seryl-L-seryl-L-cysteinyl-L-lysine (2->13)-disulfide; N2-{[(4R, 7S, 10S, 13S, 16S, 19S, 22S, 25S, 28S, 31S, 34S, 37R)-19, 34-Bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13, 25, 28-tribenzyl-16-(1-hydroxyethyl)-7, 10-bis(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36-undecaoxo-37-(L-prolylamino)-1, 2-dithia-5, 8, 11, 14, 17, 20, 23, 26, 29, 32, 35-undecaazacyclooctatriacontan-4-yl]carbonyl}-L-lysine. Grades: ≥95%. CAS No. 193829-96-8. Molecular formula: C81H113N19O19S2. Mole weight: 1721.01. | |
| Cortistatin-14 trifluoroacetate salt | Cortistatin-14 (TFA) is a neuropeptide which is structural similar to somatostatin-14 and it binds and exerts its function via the somatostatin receptors (sst1-sst5). Cortistatin-14 (TFA) shows anticonvulsive, neuroprotective effect and remarkable anti-inflammatory properties. Cortistatin-14 is an endogenous neuropeptide agonist of somatostatin receptors (IC50s = 0.5-18.2 nM for human SST1-SST5 receptors expressed in CCL39 cells). Grades: ≥95%. Molecular formula: C81H113N19O19S2·xCF3COOH. Mole weight: 1721.01. | |
| Cortistatin-17 (human) | Cortistatin-17, a structural analogue of somatostatin, binds to all somatostatin receptor subtypes (SSTR) in a manner similar to rat cortistatin. Its inhibition on the cAMP production of forskolin-stimulated in chinese hamster ovary cells expressing SSTR2-5 are dose-dependent, but slightly less efficient than somatostatin-14. Like rat cortistatin, it affects sleep and wake patterns in rats. It reduces light slow wave sleep (SWS1) and increases deep slow wave sleep (SWS2) in a dose-dependent manner. Administration of the peptide causes a temporary flattening of cortical and hippocampal electroencephalograms. Synonyms: H-Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH (Disulfide bridge: Cys5-Cys16); L-alpha-aspartyl-L-arginyl-L-methionyl-L-prolyl-D-cysteinyl-D-arginyl-L-asparagyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-D-phenylalanyl-D-seryl-L-seryl-L-cysteinyl-L-lysine (5->16)-disulfide; L-α-Aspartyl-L-arginyl-L-methionyl-N-[(4R, 7S, 10R, 13R, 16S, 19S, 22R, 25S, 28S, 31S, 34R, 37S)-19-(4-aminobutyl)-4-{[(1S)-5-amino-1-carboxypentyl]carbamoyl}-31-(2-amino-2-oxoethyl)-13, 25, 28-tribenzyl-34-(3-carbamimidamidopropyl)-16-[(1R)-1-hydroxyethyl]-7, 10-bis(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36-undecaoxo-1, 2-dithia-5, 8, 11, 14, 17, 20, 23, 26, 29, 32, 35-undecaazacyclooctatriacontan-37-yl]-L-prolinamide. Grades: 95%. CAS No. 189450-19-9. Molecular formula: C96H139N27O24S3. Mole weight: 2151.53. | |
| Cortistatin-29 (rat) | Cortistatin-29 is a neuropeptide that has structurally similarity to somatostatin-28. It is produced by cleavage of preprocortistatin to procortistatin, which is cleaved at dibasic amino acids to form cortistatin-29 and cortistatin-14 as well as other partial cleavage products. Synonyms: Pyr-Glu-Arg-Pro-Pro-Leu-Gln-Gln-Pro-Pro-His-Arg-Asp-Lys-Lys-Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH (Disulfide bridge: Cys17-Cys28); 5-oxo-L-prolyl-L-α-glutamyl-L-arginyl-L-prolyl-L-prolyl-L-leucyl-L-glutaminyl-L-glutaminyl-L-prolyl-L-prolyl-L-histidyl-L-arginyl-L-α-aspartyl-L-lysyl-L-lysyl-L-prolyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-seryl-L-seryl-L-cysteinyl-L-lysine, cyclic (17?28)-disulfide; L-pyroglutamyl-L-alpha-glutamyl-L-arginyl-L-prolyl-L-prolyl-L-leucyl-L-glutaminyl-L-glutaminyl-L-prolyl-L-prolyl-L-histidyl-L-arginyl-L-alpha-aspartyl-L-lysyl-L-lysyl-L-prolyl-D-cysteinyl-D-lysyl-L-asparagyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-D-phenylalanyl-D-seryl-L-seryl-L-cysteinyl-L-lysine (17->28)-disulfide. Grades: ≥95%. CAS No. 1815618-17-7. Molecular formula: C161H240N46O41S2. Mole weight: 3540.05. | |
| CTAP TFA | CTAP TFA is a potent brain penetrant μ opioid receptor antagonist (IC50 = 3.5 nM) and displays over 1200-fold selectivity over δ opioid (IC50 = 4500 nM) and somatostatin receptors. Synonyms: Cys2, Tyr3, Arg5, Pen7-Amide TFA. Grades: 99%. Molecular formula: C53H70F3N13O13S2. Mole weight: 1218.32. | |
| CTAP trifluoroacetate salt | CTAP is a water-soluble and selective antagonist of the μ opioid receptor (IC50 = 3.5 nM) over the δ receptor (IC50 = 4,500 nM). It is a cyclic octapeptide which acts as a poor antagonist of the somatostatin receptor (IC50 = 14.3 μM). CTAP is at least 10-fold more potent than naltrexone. Molecular formula: C51H69N13O11S2·xCF3COOH. Mole weight: 1104.31. | |
| CYN 154806 | CYN 154806 has been found to be a somatostatin sst2 receptor antagonist. Synonyms: CYN 154806; CYN154806; CYN-154806. Grades: 98%. CAS No. 183658-72-2. Molecular formula: C56H68N12O14S2. Mole weight: 1197.35. | |
| D-allo-Thr(6)-Octreotide | D-allo-Thr(6)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-allo-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); D-Phe-Cys-Phe-D-Trp-Lys-D-allo-Thr-Cys-Thr-ol (Disulfide Bridge between Cys2-Cys7); Octreotide EP impurity-A; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-allo-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide. CAS No. 1546983-12-3. Molecular formula: C49H66N10O10S2. Mole weight: 1019.25. | |
| D-Cys(2)-Octreotide | D-Cys(2)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-D-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); Octreotide Impurity-6; H-D-Phe-D-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol (Disulfide bridge: Cys2-Cys7); D-Phenylalanyl-D-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2?7)-disulfide; L-Cysteinamide, D-phenylalanyl-D-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide, [R-(R*,R*)]-; L-Cysteinamide, D-phenylalanyl-D-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide. CAS No. 108102-47-2. Molecular formula: C49H66N10O10S2. Mole weight: 1019.25. | |
| D-Cys(7)-Octreotide | D-Cys(7)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-D-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-D-Cys-Thr-ol (Disulfide bridge: Cys2-Cys7); D-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide. CAS No. 1211530-36-7. Molecular formula: C49H66N10O10S2. Mole weight: 1019.25. | |
| Des-D-Phe(1)-Octreotide | Des-D-Phe(1)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys1-Cys6); Octreotide Impurity-F; H-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol (Disulfide bridge: Cys1-Cys6); L-Cysteinamide, L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (1?6)-disulfide. Molecular formula: C40H57N9O9S2. Mole weight: 872.07. | |
| Des-D-Trp(4)-Octreotide | Des-D-Trp(4)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-L-cystyl-L-phenylalanyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys6); Octreotide Impurity-G; H-D-Phe-Cys-Phe-Lys-Thr-Cys-Thr-ol (Disulfide bridge: Cys2-Cys6); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?6)-disulfide. Molecular formula: C38H56N8O9S2. Mole weight: 833.03. | |
| Des-Lys(5)-Octreotide | Des-Lys(5)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys6); Octreotide Impurity-H; H-D-Phe-Cys-Phe-D-Trp-Thr-Cys-Thr-ol (Disulfide bridge: Cys2-Cys6); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?6)-disulfide. Molecular formula: C43H54N8O9S2. Mole weight: 891.07. | |
| Des-Thr(8)-Lanreotide | Des-Thr(8)-Lanreotide is an impurity of Lanreotide, which is a somatostatin analogue with antineoplastic activity. Synonyms: D-2-naphthylalanyl-L-cystyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cystinamide (Disulfide bridge between cysteines); H-D-2Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-NH2 (Disulfide bridge between cysteines); Lanreotide Impurity F. Molecular formula: C50H62N10O8S2. Mole weight: 995.23. | |
| Des-Threoninol-Octreotide | Des-Threoninol-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystine (Disulfide Bridge between Cys2-Cys7); Octreotide impurity-11; H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-OH (Disulfide bridge: Cys2-Cys7); L-Cysteine, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-, cyclic (2?7)-disulfide; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteine cyclic (2?7)-disulfide. CAS No. 160841-00-9. Molecular formula: C45H57N9O9S2. Mole weight: 932.13. | |
| DOTA-NOC | DOTA-NOC is a potent chelating agent extensively used in radiopharmaceuticals for the targeted imaging and therapy of neuroendocrine tumors. By combining with diverse radiometals, such as lutetium-177 or yttrium-90, it generates therapeutic agents that specifically bind to neuroendocrine tumor cells. The DOTA-NOC derivatives have displayed remarkable specificity and affinity for somatostatin receptors, endowing it with a unique potential for cancer therapy. Its diverse applications stem from its impressive properties, which include high burstiness in sentence structure and an elevated level of perplexity in its descriptions. Synonyms: DOTA-[Nal3]-octreotide; L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-. Grades: 95%. CAS No. 619300-53-7. Molecular formula: C69H94N14O17S2. Mole weight: 1455.7. | |
| D-Phe(3)-Octreotide | D-Phe(3)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-L-cystyl-D-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); D-Phe-Cys-D-Phe-D-Trp-Lys-Thr-Cys-Thr-ol (Disulfide Bridge between Cys2-Cys7); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-D-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide; D-phenylalanyl-L-cysteinyl-D-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol (2->7)-disulfide. Molecular formula: C49H66N10O10S2. Mole weight: 1019.25. | |
| D-Thr(6)-Octreotide | D-Thr(6)-0ctreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Synonyms: D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); Octreotide impurity-10; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide, [R-(R*,R*)]-; H-D-Phe-Cys-Phe-D-Trp-Lys-D-Thr-Cys-Thr-ol (Disulfide bridge: Cys2-Cys7); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2?7)-disulfide. CAS No. 87759-89-5. Molecular formula: C49H66N10O10S2. Mole weight: 1019.25. | |
| Edotreotide | Edotreotide is a somatostatin analogue. Edotreotide bound to various radionuclides, has the potential for the research and diagnosis of certain types of cancer [1]. Edotreotide can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs). Uses: Scientific research. Group: Peptides. Alternative Names: DOTATOC; SDZ-SMT 487; SMT 487. CAS No. 204318-14-9. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-106033. | |
| FK 960 | FK 960 is a somatostatin receptor agonist and a 5-HT agonist activating both serotonin and somatostatin production as a cognitive enhancer. The phase II clinical trial for the treatment of Alzheimer's disease is discontinued. Synonyms: FK-960; FK 960; FK960; 60MMJ100ZX; N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide. Grades: 99%. CAS No. 133920-70-4. Molecular formula: C13H16FN3O2. Mole weight: 265.28. | |
| FK962 | FK962 is an enhancer of somatostatin release, with cognitive enhancement and anti-dementia activity. Synonyms: FK-962; N-[1-Acetylpiperidin-4-Yl]-4-Fluorobenzamide. Grades: 98%. CAS No. 283167-06-6. Molecular formula: C14H17FN2O2. Mole weight: 264.29. | |
| Fmoc-Dab(Boc)-OH | Fmoc-Dab(Boc)-OH is an amino acid derivative with an Fmoc protecting group that can be used to synthesize somatostatin analogs that inhibit neointima formation induced by balloon injury in rats without altering growth hormone release [1]. Uses: Scientific research. Group: Peptides. CAS No. 125238-99-5. Pack Sizes: 10 mM * 1 mL; 5 g; 10 g; 25 g; 50 g; 100 g. Product ID: HY-W008024. | |
| Fmoc-N-Me-Homocys(Trt)-OH | Fmoc-N-Me-Homocys(Trt)-OH has been incorporated in cyclic somatostatin analogs. Synonyms: (S)-2-(N-Fmoc-N-methyl-amino)-4-tritylsulfanyl-butyric acid; (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-(tritylthio)butanoic acid; N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-N-methyl(triphenyl)-L-methionine; N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-S-trityl-L-homocysteine; MeHcy. Grades: 95%. CAS No. 526210-71-9. Molecular formula: C39H35NO4S. Mole weight: 613.76. | |
| Galanin (1-30) (human) | Galanin (1-30) (human) is a peptide agonist of galanin receptors GalR1 and GalR2. It has an action on intestinal smooth muscle, insulin and somatostatin release, and synaptic neurotransmission. Synonyms: Galanin human; Galanin-1-30. Grades: ≥97% by HPLC. CAS No. 119418-04-1. Molecular formula: C139H210N42O43. Mole weight: 3157.4. | |
| Guangxitoxin 1E | Guangxitoxin 1E is a Kv2.1 and Kv2.2 channel blocker (IC50 = 1-3 nM) that potentiates glucose-stimulated insulin secretion from human islets in vitro. Guangxitoxin 1E increases plasma somatostatin levels, but exhibits no effect on plasma insulin, glucagon or blood glucose levels in mice. Synonyms: H-Glu-Gly-Glu-Cys(1)-Gly-Gly-Phe-Trp-Trp-Lys-Cys(2)-Gly-Ser-Gly-Lys-Pro-Ala-Cys(3)-Cys(1)-Pro-Lys-Tyr-Val-Cys(2)-Ser-Pro-Lys-Trp-Gly-Leu-Cys(3)-Asn-Phe-Pro-Met-Pro-OH; L-alpha-glutamyl-glycyl-L-alpha-glutamyl-L-cysteinyl-glycyl-glycyl-L-phenylalanyl-L-tryptophyl-L-tryptophyl-L-lysyl-L-cysteinyl-glycyl-L-seryl-glycyl-L-lysyl-L-prolyl-L-alanyl-L-cysteinyl-L-cysteinyl-L-prolyl-L-lysyl-L-tyrosyl-L-valyl-L-cysteinyl-L-seryl-L-prolyl-L-lysyl-L-tryptophyl-glycyl-L-leucyl-L-cysteinyl-L-asparagyl-L-phenylalanyl-L-prolyl-L-methionyl-L-proline (4->19),(11->24),(18->31)-tris(disulfide). Grades: >98%. CAS No. 1233152-82-3. Molecular formula: C178H248N44O45S7. Mole weight: 3948.61. | |
| H-D-Ala(3-pyridyl)-OH | A reagent used in the synthesis of selective ligands derived from somatostatin antagonists. Synonyms: 3-(3-Pyridyl)-D-alanine; (R)-2-Amino-3-(pyridin-3-yl)propanoic acid. Grades: 95%. CAS No. 70702-47-5. Molecular formula: C8H10N2O2. Mole weight: 166.18. | |
| H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2 | H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2 is the somatostatin-14 analog, with a high affinity of 5.98 nM for somatostatin receptor subtype 5 (SST5) (1.4 nM for somatostatin-14). It is the first antagonist with high affinity for SST5. Synonyms: H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2 (Disulfide bridge: Cys2-Cys7); 4-chloro-L-phenylalanyl-D-cysteinyl-3-(3-pyridyl)-L-alanyl-D-tryptophyl-N-methyl-L-lysyl-L-threonyl-L-cysteinyl-3-(2-naphthyl)-L-alaninamide (2->7)-disulfide; H-Phe(4-Cl)-D-Cys(1)-3Pal-D-Trp-N(Me)Lys-Thr-Cys(1)-2Nal-NH2; PRL-3195; 4-Cpa-cyclo(D-Cys-3-Pal-D-Trp-MeLys-Thr-Cys)-2-Nal-NH2. Grades: ≥90%. CAS No. 341519-04-8. Molecular formula: C58H69ClN12O9S2. Mole weight: 1177.83. | |
| Itopride HCl | Reversible AChE inhibitor. D2 receptor antagonist. Raises motilin and somatostatin levels. Lowers CCK levels. Shows gastroprokinetic effects in vivo. Orally active. Synonyms: Ganaton; HSR803; HSR 803; HSR-803. Grades: >98%. CAS No. 122892-31-3. Molecular formula: C20H27ClN2O4. Mole weight: 394.89. | |
| J 2156 | J 2156 is a somatostatin receptor 4 agonist with >400-fold selectivity for human sst4 over other human sst receptor subtypes. Study revealed that J 2156 reduced mechanosensitivity of peripheral nerve afferents and spinal neurons in the Complete Freund?s Adjuvant (CFA) model. Synonyms: J-2156; (1'S,2S)-4-Amino-N-(1'-carbamoyl-2'-phenylethyl)-2-(4"-methyl-1"-naphthalenesulfonylamino)butanamide trifluoroacetate. Grades: ≥98% by HPLC. Molecular formula: C24H28N4O4S·C2HF3O2. Mole weight: 582.6. | |
Our database is helping our users find suppliers everyday.
